D
Drugs.com
Comprehensive drug information, interactions, and side effect database for GLP-1 medications
Drug ComparisonsNationwide
← Directory
Z
Zepbound
Official Eli Lilly resource for Zepbound tirzepatide for chronic weight management
About
The official Eli Lilly site for Zepbound, tirzepatide, FDA approved for chronic weight management and also for moderate to severe obstructive sleep apnea in adults with obesity. Tirzepatide acts on two receptors, GIP and GLP-1, rather than the single GLP-1 receptor that semaglutide targets, which is the pharmacological difference behind most head-to-head comparisons. The site carries prescribing information, dosing, side effect data, and manufacturer savings options.
Related providers
O
Ozempic
Official Novo Nordisk resource for Ozempic semaglutide information and support
Drug ComparisonsNationwide
W
WebMD
Medical reference and drug information for patients researching GLP-1 medications
Drug ComparisonsNationwide